2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$65.67-$0.02 (-0.02%)
Price as of Sep 11, 2026 7:30 PM EDT- $12.7BMarket Cap
- 21.43%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$65.67-$0.02 (-0.02%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $65.68 | ||
Change | +$0.17 (+0.26%) | ||
Open | $65.96 | ||
High | $66.05 | ||
Low | $65.28 | ||
Previous Close | $65.51 | ||
Volume | 1,604,794 | ||
30-Day Average Volume | 1,865,708 | ||
1-Week Change | -1.28% | ||
1-Month Change | -5.56% | ||
1-Year Change | 21.43% | ||
3-Year Change | -27.71% | ||
5-Year Change | -15.77% | ||
Fundamentals | |||
Shares Outstanding | 193.6M | ||
Total Assets | $11.7B | ||
Market Cap | $12.7B | ||
Enterprise Value | $16.0B | ||
Period: QTR TTM FY | |||
Revenue | $984.4M | ||
Net Income | $44.8M | ||
Free Cash Flow | $139.3M | ||
EBIT | $122.1M | ||
EBITDA | $219.8M | ||
Net Working Capital | $2.3B | ||
EPS | $0.23 | ||
Enterprise Value/EBITDA | 73 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 2 | ||
P/E | 286 | ||
PEG | -5 | ||
Price/Free Cash Flow | 91 | ||
Price/Operating Cash Flow | 76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue